Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of urtica laetevirens in preparation of medicine for treating acute granulocytic monocytic leukemia (M5 type)

A single-cell, leukemia technology, used in drug combinations, anti-tumor drugs, pharmaceutical formulations, etc., can solve problems such as acute myeloid-monocytic leukemia that have not yet been seen

Inactive Publication Date: 2017-01-04
单晓春
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report about the treatment of acute myelomonocytic leukemia (M5 type) with Hara seaweed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0009] The present invention will be further described below in conjunction with embodiment.

[0010] Clinical data Therapeutic effect of Hara seaweed extract on acute myelomonocytic leukemia (M5 type)

[0011] The Hara seaweed extract is prepared by the following method: take 150 grams of dried Hara seaweed, add water and decoct it for 15 minutes (the amount of water added is 8 times the mass of the Hara seaweed), and then it is obtained (this is the amount of one dose).

[0012] Patient information: 24 patients, all suffering from acute myelomonocytic leukemia (M5 type), aged 5 to 44 years.

[0013] Treatment plan: All patients took Hara seaweed extract, one dose per day, divided into 3 times, and the curative effect was observed after 2 months of treatment.

[0014] Efficacy evaluation criteria:

[0015] Complete remission (CR): bone marrow: leukemia cells ≤ 5%, the degree of proliferation is normal, and the ratio of each line is basically normal. Hemogram Hb≥100g / L, neu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a urtica laetevirens / urtica laetevirens extract in preparation of a medicine for treating acute granulocytic monocytic leukemia (M5 type). The urtica laetevirens extract is prepared by the following method: decocting fresh or dried urtica laetevirens with water for 15 minutes, (optimally adding water which is 6-10 times of the mass of urtica laetevirens). The application of urtica laetevirens in treatment of acute granulocytic monocytic leukemia (M5 type) is discovered for the first time, and a corresponding preparation is prepared according to conclusion of years of clinical experience. Clinical application proves that the preparation has a remarkable curative effect.

Description

technical field [0001] The invention relates to the application of Hara seaweed in the preparation of a medicine for treating acute myelomonocytic leukemia (M5 type) with significantly increased white blood cells and significantly decreased platelets. Background technique [0002] Leukemia is a malignant clonal disease of hematopoietic stem cells. Clonal leukemia cells proliferate and accumulate in bone marrow and other hematopoietic tissues due to mechanisms such as uncontrolled proliferation, differentiation disorder, and apoptosis inhibition, and infiltrate other tissues and organs, while normal hematopoiesis is inhibited. Clinically, different degrees of anemia, hemorrhage, infection, fever, enlargement of liver, spleen, lymph nodes and bone pain can be seen. According to reports, the incidence of leukemia in various regions of my country occupies the sixth place among various tumors. Acute myelomonocytic leukemia (M5 type) belongs to a type of acute non-lymphocytic le...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61P35/02
CPCA61K36/185A61K2236/331
Inventor 单晓春
Owner 单晓春
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com